Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player
Riccardo Palmisano is CEO of MolMed, the most important Italian biotech, which focuses on gene…
04/12/2017 - 7 minutes
CAR-T
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
14/11/2017 - 2 minutes
More News! Novartis is going for EMA Approval for CAR-T Therapy
Try as we might, we can’t cover all the biotech news out there! Here’s a roundup…
10/11/2017 - 1 minute
Update: Clinical Holds Lifted for First Off-the-Shelf CAR-T Therapy
UPDATE: The FDA has lifted both clinical holds provided that Cellectis decreases the dose of…
07/11/2017 - 3 minutes
The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’
Gilead's CAR-T cell therapy Yescarta has been approved by the FDA, making it the first…
19/10/2017 - 3 minutes
Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?
Everything you need to know about CAR-T, a revolutionary cell therapy for cancer. You might…
18/10/2017 - 2 minutes
Belgian Biotech’s Leukemia CAR-T Treatment Leaves Patient Cancer-Free
Celyad has announced early results from a clinical trial, where a patient has been cleared of…
04/10/2017 - 2 minutes
British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies
Autolus, based in London, has raised €68M in Series C to continue developing its T cell…
26/09/2017 - 3 minutes
CAR-T is Nearly Here: How Will It Be Delivered?
As we anticipate the first-ever CAR-T therapy market approval we look at the important aspect…
07/09/2017 - 4 minutes
The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue
Gilead has just splashed out $12 billion for Kite Pharma, and the FDA is currently…
06/09/2017 - 6 minutes
The FDA Approves the First CAR-T Cell Therapy for Cancer
The FDA has approved Novartis' CAR-T therapy Kymriah, opening the way for a new generation…
31/08/2017 - 3 minutes
Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’…
29/08/2017 - 2 minutes
